PlainRecalls
FDA Devices Moderate Class II Ongoing

HemosIL Heparin Calibrators; Part Number: 0020300600; in vitro diagnostic

Reported: February 5, 2025 Initiated: December 18, 2024 #Z-1020-2025

Product Description

HemosIL Heparin Calibrators; Part Number: 0020300600; in vitro diagnostic

Reason for Recall

Control indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range.

Details

Units Affected
10,952 units (5,303 US, 5,649 OUS)
Distribution
Worldwide - US Nationwide and the countries of Andorra, Algeria, Armenia, Australia, Austria, Belarus, Belgium, Brazil, Brunei Darussalam, Bulgaria, Canada, China, Colombia, Cyprus, Czechia, Denmark, Finland, France, Georgia, Germany, Gibraltar, Greece, Hong Kong, Hungary, India, Iran (Islamic Republic of), Ireland, Israel, Italy, Japan, Korea (the Republic of), Kuwait, Kyrgyzstan, Lebanon, Lithuania, Luxembourg, Macao, Malaysia, Mexico, Netherlands (the), Norway, Philippines (the), Poland, Portugal, Qatar, Romania, Russian Federation (the), Saudi Arabia, Singapore, Spain, Sweden, Switzerland, Taiwan (Province of China), Thailand, Tunisia, Turkey, United Arab Emirates, United Kingdom, Viet Nam.
Location
Bedford, MA

Frequently Asked Questions

What product was recalled?
HemosIL Heparin Calibrators; Part Number: 0020300600; in vitro diagnostic. Recalled by Instrumentation Laboratory. Units affected: 10,952 units (5,303 US, 5,649 OUS).
Why was this product recalled?
Control indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 5, 2025. Severity: Moderate. Recall number: Z-1020-2025.